Journal of Rare Cardiovascular Diseases最新文献

Association of fibrinogen and D‑dimer levels with severity of acute coronary syndromes 纤维蛋白原和D -二聚体水平与急性冠状动脉综合征严重程度的关系

Journal of Rare Cardiovascular Diseases Pub Date : 2021-02-16 DOI: 10.20418/jrcd.v0i0.409.g327

M. Prabhu, Jagadish Madireddy, Ranjan Shetty, Weena Stanley

{"title":"Association of fibrinogen and D‑dimer levels with severity of acute coronary syndromes","authors":"M. Prabhu, Jagadish Madireddy, Ranjan Shetty, Weena Stanley","doi":"10.20418/jrcd.v0i0.409.g327","DOIUrl":"https://doi.org/10.20418/jrcd.v0i0.409.g327","url":null,"abstract":"Background: Acute coronary syndromes (ACSs) are the primary cause of mortality worldwide. The aim of the study was to assess the as‑sociations of serum fibrinogen and plasma D‑dimer levels with angiographic severity of atherosclerotic lesions as well as the presence of in‑hospital complications and complications at 30‑day follow‑up in patients with ACS. Methods: This was a prospective study including 107 patients with ACS. Severity of CAD was assessed by the Gensini score. Correlations of D‑dimer and fibrinogen levels with complica‑tions such as heart failure, arrhythmia, recurrent angina, and cardiac death were assessed using the Pearson correlation coefficient and the receiver operating characteristic curve analysis. Results: The mean age of patients was 61±10.9 years. Mean serum fibrinogen levels were higher in individuals with severe left ventricular (LV) dysfunction than in those with moderate and mild LV dysfunction (444 mg/dl, 404 mg/dl, and 330 mg/dl, respectively). Similarly, the mean plasma D‑dimer level was higher in individuals with severe ACS (1.03 μg/ml) than in those with moderate (1.88 μg/ml) and mild ACS (3.5 μg/ml). Conclusion: Our study revealed that patients with higher serum fibrinogen levels tend to have more severe ACS, greater LV dysfunction, and a higher rate of complications. Therapies aimed at reducing fibrinogen levels might help reduce mortality and morbidity in patients with ACS.","PeriodicalId":37488,"journal":{"name":"Journal of Rare Cardiovascular Diseases","volume":"16 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-02-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83529249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Journal of Rare Cardiovascular Diseases in EuroPub database 欧洲pub数据库罕见心血管疾病杂志

Journal of Rare Cardiovascular Diseases Pub Date : 2020-12-02 DOI: 10.20418/JRCD.V4I4.418.G322

P. Podolec

引用次数: 0

Autoimmune hepatitis induced by bosentan in a patient with pulmonary arterial hypertension (RCD code: II‐1A.1; VIII) 波生坦致肺动脉高压患者自身免疫性肝炎1例(RCD代码:II‐1A.1;八世)

Journal of Rare Cardiovascular Diseases Pub Date : 2020-09-02 DOI: 10.20418/JRCD.VOL4NO3.396

O. Kalashnykova, L. Vasilyeva, Alina Vasilevna Khomich

引用次数: 0

Survival analysis of time to develop cardiovascular complications and its predictors among hypertensive patients treated in the Ayder Comprehensive Specialized Hospital, Ethiopia: a retrospective cohort study (RCD code: VIII) 埃塞俄比亚Ayder综合专科医院高血压患者心血管并发症发生时间及其预测因素的生存分析:一项回顾性队列研究(RCD代码:VIII)

Journal of Rare Cardiovascular Diseases Pub Date : 2020-09-02 DOI: 10.20418/JRCD.VOL4NO3.386

D. B. Tadesse, Gebre Yitayih, Weyzer Tilahun, Gebreamlak Gebremedhn, Kiros Belay, B. Hailu, Yohannes Ashebir, Gebre Teklemariam Demoz, Mulugeta Molla

{"title":"Survival analysis of time to develop cardiovascular complications and its predictors among hypertensive patients treated in the Ayder Comprehensive Specialized Hospital, Ethiopia: a retrospective cohort study (RCD code: VIII)","authors":"D. B. Tadesse, Gebre Yitayih, Weyzer Tilahun, Gebreamlak Gebremedhn, Kiros Belay, B. Hailu, Yohannes Ashebir, Gebre Teklemariam Demoz, Mulugeta Molla","doi":"10.20418/JRCD.VOL4NO3.386","DOIUrl":"https://doi.org/10.20418/JRCD.VOL4NO3.386","url":null,"abstract":"Objective: Although hypertension is the leading cause of cardiovascular complications, time to develop cardiovascular complications among hypertensive patients has not been adequately investigated in Ethiopia. Therefore, the aim of this study was to assess time to develop cardiovascular complications and its predictors among adult hypertensive patients at the Ayder Comprehensive Specialized Hospital, Ethiopia. Result: A total of 578 hypertensive patients from the Cardiology Department were included in the study and followed for a total of 60 months (median 28 months). Half of the participants (290, 50.2%) were females. The median age of subjects was 54 years. Out of the 578 hypertensive patients who were analysed, 25.4% of them developed a cardiovascular complication. The incidence rate was 8.25 per 1000 persons per month. Significant predictors in the development of cardiovascular complications among hypertensive patients were age [AHR = 1.03 (95% CI=1.016, 1.046)], baseline cardiovascular complications [AHR=3.03 (95% CI=2.009, 4.870)], proteinuria [AHR=3.9 (95% CI=1.3, 11.68)], baseline systolic blood pressure [AHR =1.01 (95% CI=1.003, 2.012)], and baseline diastolic blood pres‐sure [AHR = 1.013 (95% CI=1.005, 2.021)]. JRCD 2019; 4 (4): 96-100.","PeriodicalId":37488,"journal":{"name":"Journal of Rare Cardiovascular Diseases","volume":"13 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75013920","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1

Amyloid cardiomyopathy – the true burden, current approach to diagnosis and treatment (RCD code III‐3A.1, III‐3A.2) 淀粉样蛋白心肌病——真正的负担，当前的诊断和治疗方法(RCD代码III‐3A)。1,第三还是3 a)

Journal of Rare Cardiovascular Diseases Pub Date : 2020-09-02 DOI: 10.20418/JRCD.VOL4NO3.398

K. Holcman, M. Kostkiewicz, P. Podolec, P. Rubis

引用次数: 0

An Extremely Rare Congenital Association: Uni- cuspid Aortic Valve with Left Ventricular Noncom- paction (RCD code: III-5A.1.o) 一种极其罕见的先天性关联:单尖瓣主动脉瓣与左心室不闭合(RCD代码:III-5A.1.o)

Journal of Rare Cardiovascular Diseases Pub Date : 2020-09-02 DOI: 10.20418/JRCD.VOL4NO3.390

S. Tatari

引用次数: 0

Critical value of the balloon occlusion test of a coronary fistula in a patient with pulmonary atresia and intact ventricular septum (RCD code: I 1C.4; II 2A.1) 肺动脉闭锁合并室间隔完整患者冠状动脉瘘球囊闭塞试验的临界值(RCD代码:i1c .4; - i2a .1)

Journal of Rare Cardiovascular Diseases Pub Date : 2020-01-31 DOI: 10.20418/JRCD.VOL4NO3.357

Jacek Kuźma, P. Weryński, P. Skorek, M. Rączka, Katarzyna Konarska

引用次数: 0

Tachycardia induced cardiomyopathy due to dual atrioventricular nodal non reentrant tachycardia (RCDD code: VI 1A 9) 双房室结性非折返性心动过速致心肌病(RCDD代码:VI 1A 9)

Journal of Rare Cardiovascular Diseases Pub Date : 2020-01-31 DOI: 10.20418/JRCD.VOL4NO3.387

U. Chernyaha-Royko, M. Sorokivskyy, A. Aker, B. Kravchuk, V. Kuts, O. Zharinov

引用次数: 0

Prevalence and characteristics of patients with solitary coronary artery fistulas in 12,757 all comer adult patients undergoing coronary angiography (RCD code: I 1C.4) 12757例接受冠状动脉造影的成年患者单发冠状动脉瘘的患病率及特点(RCD代码:i1c .4)

Journal of Rare Cardiovascular Diseases Pub Date : 2020-01-31 DOI: 10.20418/JRCD.VOL4NO3.384

J. Chmiel, M. K. Książek, Grażyna Świtacz, J. Dradrach, Iwaszczuk, Leszek Drabik, P. Podolec, P. Musialek

{"title":"Prevalence and characteristics of patients with solitary coronary artery fistulas in 12,757 all comer adult patients undergoing coronary angiography (RCD code: I 1C.4)","authors":"J. Chmiel, M. K. Książek, Grażyna Świtacz, J. Dradrach, Iwaszczuk, Leszek Drabik, P. Podolec, P. Musialek","doi":"10.20418/JRCD.VOL4NO3.384","DOIUrl":"https://doi.org/10.20418/JRCD.VOL4NO3.384","url":null,"abstract":"Introduction Coronary artery fistula (CAF) is a rare anomaly, mostly congenital, defined as an abnormal direct connection between one of the coronary arteries and a heart chamber or major vessel. In case of coronary steal, CAF may manifest with symptoms of stable coro‐ nary disease (CAD). Methods We investigated medical records of all adult patients who underwent coronary angiography (CAG) from 1 July 2009 to 30 June 2019. Patients with solitary CAF were selected. Coronary artery‐ventricular multiple microfistulas (MMFs) were recorded but were no object for further analysis. The CAFs were grouped depending on the origin and termination. Clinical symptoms, comorbidities and past medical history were analyzed. Results 26 solitary CAFs were found in 22 (0.17%) and 20 MMFs in 16 (0.13%) out of 12,757 patients who underwent CAG for any reason in that period. Indication for CAG varied among study group. Left coronary artery (LCA) gave origin to majority (57.69%) of fistulas. Pulmonary artery (PA) was the most common drainage site (69.23%). 17 patients had HA, 15 suffered from chest pain or dyspnoea, 13 had dyslipidemia, and half had CAD. Conclusion The incidence of solitary CAF in the sample of all‐comer population of Polish patients undergoing CAG was 0.17%. LCA was the most common artery of origin and PA was the most frequent drainage site. The indication for CAG varied among patients. Majority of patients suffered from chest pain or dyspnea, had HA, dyslipidemia, and half had CAD. Moreover, the incidence of MMF was 0.13%. JRCD 2019; 4 (3): 42-46.","PeriodicalId":37488,"journal":{"name":"Journal of Rare Cardiovascular Diseases","volume":"13 4 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76564034","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Early diagnosis is crucial for successful treatment of pulmonary arterial hypertension: 2 cases of late diagnosis (RCD code: II 1A.1) 早期诊断是成功治疗肺动脉高压的关键:晚期诊断2例(RCD代码:i1a .1)

Journal of Rare Cardiovascular Diseases Pub Date : 2020-01-29 DOI: 10.20418/JRCD.VOL4NO3.389

Maryla Mianowana, Łukasz Siudak, P. Blaszczak

引用次数: 0